Series B - Applied Therapeutics - 2019-02-01 - Crunchbase

Applied Therapeutics raised $25000000 on 2019-02-01 in Series B. Alexandria Venture Investments Alexandria Venture Investments is a venture capital firm that develops the work in …

CouponFollow Extension

$25000000
OFF

Series B - Applied Therapeutics - 2019-02-01 - Crunchbase

4 weeks from now

Applied Therapeutics raised $25000000 on 2019-02-01 in Series B. Alexandria Venture Investments Alexandria Venture Investments is a venture capital firm that develops the work in …

crunchbase.com

$10.00
OFF

Applied Therapeutics - Funding, Financials, Valuation & Investors

4 weeks from now

Applied Therapeutics is registered under the ticker NASDAQ:APLT . Their stock opened with $10.00 in its May 13, 2019 IPO. Applied Therapeutics is funded by 14 investors. Janus …

crunchbase.com

$25000000
OFF

Series B - Allay Therapeutics - 2019-01-01 - Crunchbase

4 weeks from now

Jan 1, 2019 · Allay Therapeutics raised $25000000 on 2019-01-01 in Series B. New Enterprise Associates New Enterprise Associates is a venture capital firm that focuses on investments in …

crunchbase.com

$100
OFF

Iambic Therapeutics Announces Close Of Oversubscribed $100 …

4 weeks from now

Oct 3, 2023 · ‍SAN DIEGO, CA – Iambic Therapeutics (formerly known as Entos), a biotechnology company developing novel therapeutics from its unique generative AI discovery platform, …

iambic.ai

$135000000
OFF

Series B - Beam Therapeutics - 2019-03-06 - Crunchbase

4 weeks from now

Mar 6, 2019 · Beam Therapeutics raised $135000000 on 2019-03-06 in Series B. endpts.com — Gene editing upstart backed by Broad star Feng Zhang nabs $135M, blueprinting a platform …

crunchbase.com

$36
OFF

AppliedVR Raises $36 Million Series B To Scale Comprehensive …

4 weeks from now

LOS ANGELES, Nov. 11, 2021 /PRNewswire/ -- AppliedVR, a pioneer advancing the next generation of immersive therapeutics, today announced $36 million in series B funding, …

businessinsider.com

$75
OFF

Alpha-9 Theranostics Announces Oversubscribed $75 Million …

4 weeks from now

Dec 14, 2022 · The company looks forward to expanding these relationships with the Series B proceeds. ... headquartered in both Boston and Vancouver, was founded in 2019 by François …

a9oncology.com

$91
OFF

Treadwell Therapeutics Announces The Closing Of A $91 Million …

4 weeks from now

Nov 18, 2021 · New York and Hong Kong – November 18th, 2021 – Treadwell Therapeutics, a clinical-stage biotechnology company developing novel, cross-modality medicines for unmet …

treadwelltx.com

$270
OFF

The Week’s 10 Biggest Funding Rounds: Biotech Goes

4 weeks from now

Apr 28, 2023 · The startup closed a $270 million Series A led by Arch Venture Partners. Orbital is looking to expand RNA-based medicines including next-generation vaccines, …

crunchbase.com

$70
OFF

From Founding Investor Versant Million Series B Financing Led …

4 weeks from now

9/16/21, 8:18 AM Lycia Therapeutics Announces $70 Million Series B Financing ... Versant Ventures founded Lycia in 2019 within the rm’s San Diego-based. Inception labs in …

versantventures.com

$64600000
OFF

Post-IPO Equity - Applied Therapeutics - 2021-02-11 - Crunchbase

4 weeks from now

Feb 11, 2021 · Applied Therapeutics raised $64600000 on 2021-02-11 in Post-IPO Equity. Search Crunchbase. ... Funding Round. Post-IPO Equity - Applied Therapeutics . Save . …

crunchbase.com

$100
OFF

Scribe Therapeutics Closes Series B Round With $100M To Target …

4 weeks from now

Mar 31, 2021 · Molecular engineering company Scribe Therapeutics has completed an oversubscribed $100 million round of Series B financing to further develop its “CRISPR by …

crunchbase.com

$60900000
OFF

Series B - Lyndra Therapeutics - 2019-02-11 - Crunchbase

4 weeks from now

Feb 11, 2019 · Lyndra Therapeutics raised $60900000 on 2019-02-11 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …

crunchbase.com

$32139578
OFF

Series B - INNOVO By Atlantic Therapeutics - 2019-01-07

4 weeks from now

Jan 7, 2019 · INNOVO by Atlantic Therapeutics raised $32139578 on 2019-01-07 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. …

crunchbase.com

FAQs about Series B - Applied Therapeutics - 2019-02-01 - Crunchbase Coupon?

What happened to Series B investment in 2022?

Per Crunchbase data, Series B investment in the second half of 2022 was down over 60% from the year-ago period. For a sense of how far things have fallen, we chart out Series B deal counts and funding for the past nine quarters below. Why Series B? So why single out Series B for scrutiny? ...

Is Series B funding still a good investment?

When technology and biotech valuations began to tumble last year, U.S. Series B funding held up at first, offering one of the brighter areas in a more bearish investment environment. That’s no longer the case. In recent months, Series B funding to U.S. startups has fallen sharply. ...

How many startups have raised a series B?

A minority of Series A-funded startups actually raise a B round in the next few years. Per Crunchbase data, out of over 4,400 U.S. companies that secured a Series A in 2020 or 2021, peak years for venture funding, just over 1,600 have raised a Series B. . ...

What are the biggest Series B investments in 2024?

Notably, several of the biggest Series B investments this year went to companies that closed their prior round not too long ago. The most high profile example is Elon Musk ’s xAI. The generative AI startup closed the largest Series B of 2024 — a $6 billion financing — six months after raising its previous round. ...

Are Series B investors avoiding fintech?

It’s not uncommon to see this sector lead the ranks, as scaling a biotech is an expensive undertaking. Also noteworthy is what we’re not seeing. In particular, Series B investors are avoiding fintech. None of the 20 largest funding recipients this year were categorized as fintech companies by Crunchbase. ...

What is the purpose of Iambic's Series B funding?

Iambic's Series B funding, totaling $100 million, is intended to advance multiple AI-discovered candidates into the clinic and expand the pipeline. This demonstrates the potential of the Iambic platform to deliver better therapeutics to patients in less time, with optimized target product profiles for greater likelihood of clinical success. ...